Factors associated with mortality in tuberculosis patients

Journal of Research in Medical Sciences

Volumn 18, Issue 1, 2013, Pages 52-55

  Alavi Naini, Roya ^a   Moghtaderi, Ali ^a   Metanat, Maliheh ^a   Mohammadi, Mehdi ^a   Zabetian, Mahnaz ^a  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Mortality; Risk factors; Tuberculosis

Indexed keywords

ADULT; ANEMIA; ARTICLE; DIABETES MELLITUS; DRUG DEPENDENCE; FEMALE; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; TUBERCULOSIS;

EID: 84879158640     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. The U.S. Government and Global Tuberculosis. Fact sheet. US Global Health Policy; 2012. Available from: http://www.kff.org/globalhealth/upload/7883-05.pdf. [Last accessed on 2012 Dec 21]
2. Waitt CJ, Squire SB. A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int J Tuberc Lung Dis 2011;15:871-885.
3. Horne DJ, Hubbard R, Narita M, Exarchos A, Park DR, Goss CH. Factors associated with mortality in patients with Tuberculosis. BMC Infect Dis 2010;10:258. Available from: http://www.biomedcentral.com/1471-2334/10/258. [Last accessed on 2012 May 25].
4. Khan K, Campbell A, Wallington T, Gardam M. The impact of physician training and experience on the survival of patients with active tuberculosis. CMAJ 2006;175:749-753.
5. Pablos-Mendez A, Sterling TR, Frieden TR. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA 1996;276:1223-1228.
6. Anyama N, Bracebridge S, Black C, Niggebrugge A, Griffin SJ. What happens to people diagnosed with tuberculosis? A population-based cohort. Epidemiol Infect 2007;135:1069-1076.
7. Sterling TR, Zhao Z, Khan A, Chaisson RE, Schluger N, Mangura B, et al. Mortality in a large tuberculosis treatment trial: Modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis 2006;10:542-549.
8. CDC. Reported tuberculosis in Sistan and Baluchestan. Regional Health Center, Zahedan University of Medical Sciences. Iran: CDC; 2009.
9. Wang JY, Liu CH, Hu FC, Chang HC, Liu JL, Chen JM, et al. Risk factors of hepatitis during anti-tuberculous treatment and implications of hepatitis virus load. J Infect 2011;62:448-455.
10. Marks SM, Magee E, Robison V. Patients diagnosed with tuberculosis at death or who died during therapy: Association with the human immunodeficiency virus. Int J Tuberc Lung Dis 2011;15:465-470.
11. Balabanova Y, Nikolayevskyy V, Ignatyeva O, Kontsevaya I, Rutterford CM, Shakhmistova A, et al. Survival of civilian and prisoner drug-sensitive, multi-and extensive drug-resistant tuberculosis cohorts prospectively followed in Russia. PLoS One 2011;6:e20531.
12. Tafuri S, Martinelli D, Melpignano L, de Palma M, Quarto M, Prato R, et al. Tuberculosis screening in migrant reception centers: Results of a 2009 Italian survey. Am J Infect Control 2011;39:495-499.
13. Low S, Ang LW, Cutter J, James L, Chee CB, Wang YT, et al. Mortality among tuberculosis patients on treatment in Singapore. Int J Tuberc Lung Dis 2009;13:328-334.
14. Amnuaiphon W, Anuwatnonthakate A, Nuyongphak P, Sinthuwatanawibool C, Rujiwongsakorn S, Nakara P, et al. Factors associated with death among HIV-uninfected TB patients in Thailand, 2004-2006. Trop Med Int Health 2009;14:1338-1346.
15. Nguyen LT, Hamilton CD, Xia Q, Stout JE. Mortality before or during treatment among tuberculosis patients in North Carolina, 1993-2003. Int J Tuberc Lung Dis 2011;15:257-262,.
16. Jeon DS, Kim DH, Kang HS, Hwang SH, Min JH, Kim JH, et al. Survival and predictors of outcomes in non-HIV-infected patients with extensively drug-resistant tuberculosis. Int J Tuberc Lung Dis 2009;13:594-600.
17. Liu CH, Li L, Chen Z, Wang Q, Hu YL, Zhu B, et al. Characteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: A 13-year experience. PLoS One 2011;6:e19399.
18. Pardeshi G. Survival analysis and risk factors for death in tuberculosis patients on directly observed treatment-short course. Indian J Med Sci 2009;63:180-186.
19. Vilariça AS, Diogo N, André M, Pina J. Adverse reactions to antituberculosis drugs in in-hospital patients: Severity and risk factors. Rev Port Pneumol 2010;16:431-451